PATENT CLAIM ANALYSIS

Application Number: 16178309
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "142100"]

Abstract:
The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.

Claim (Index 12):
A stable aqueous pharmaceutical composition comprising:\n a) adalimumab; b) sodium glutamic acid; c) an amino acid; and d) polysorbate 80; wherein the composition is free of i) mannitol, ii) citrate and phosphate buffers, and iii) sodium chloride, and wherein the composition has a pH of about 5 to about 6.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 98.0
- Lexical Diversity: 1.36364
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16023205', '15799851', '15729243', '15726195', '15726165']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7749177718443391
- 35 USC 102 Novelty (BERT): 0.6410266373196065
- Combined Prediction Score: 0.7615286583918658
- Mean Citation Score: 605.572948
- Max Citation Score: 617.5789
- Similarity Product: 579.6756440564873

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test